213
Participants
Start Date
October 10, 2024
Primary Completion Date
October 14, 2027
Study Completion Date
October 14, 2027
BMS-986484
Specified dose on specified days
Nivolumab
Specified dose on specified days
Oxaliplatin
Specified dose on specified days
Capecitabine
Specified dose on specified days
Fluorouracil
Specified dose on specified days
Calcium folinate
Specified dose on specified days
RECRUITING
St Vincent's Hospital, Darlinghurst
RECRUITING
Lyell McEwin Hospital, Elizabeth Vale
RECRUITING
START Midwest, Grand Rapids
RECRUITING
Sanford Cancer Center, Sioux Falls
RECRUITING
NEXT Oncology, San Antonio
RECRUITING
University of Arizona Cancer Center, Tucson
RECRUITING
USC/Norris Comprehensive Cancer Center, Los Angeles
RECRUITING
Princess Margaret Cancer Centre, Toronto
RECRUITING
Centre Hospitalier de l'Université de Montréal, Montreal
NOT_YET_RECRUITING
Local Institution - 0023, Chuo-ku
NOT_YET_RECRUITING
Local Institution - 0022, Kashiwa
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY